Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 10/2016

01-10-2016 | Letter to the editor

RE: Effects of adjuvant chemotherapy on recurrence, survival and quality of life in stage II colon cancer patients: a 24-month follow-up

Authors: F. N. van Erning, P. A. J. Vissers, C. J. A. Punt, V. E. P. P. Lemmens

Published in: Supportive Care in Cancer | Issue 10/2016

Login to get access

Excerpt

Dear editor, …
Literature
1.
Lewis C, Xun P, He K (2016) Effects of adjuvant chemotherapy on recurrence, survival, and quality of life in stage II colon cancer patients: a 24-month follow-up. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 24(4):1463–1471. doi:10.​1007/​s00520-015-2931-2 CrossRef
2.
Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, Brouwers M, Charette M, Haller DG (2004) American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22(16):3408–3419. doi:10.​1200/​JCO.​2004.​05.​063 CrossRefPubMed
3.
Verhoeff SR, van Erning FN, Lemmens VE, de Wilt JH, Pruijt JF (2016) Adjuvant chemotherapy is not associated with improved survival for all high risk factors in stage II colon cancer. Int J Cancer. doi:10.​1002/​ijc.​30053 PubMed
4.
5.
6.
Metadata
Title
RE: Effects of adjuvant chemotherapy on recurrence, survival and quality of life in stage II colon cancer patients: a 24-month follow-up
Authors
F. N. van Erning
P. A. J. Vissers
C. J. A. Punt
V. E. P. P. Lemmens
Publication date
01-10-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 10/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3267-2

Other articles of this Issue 10/2016

Supportive Care in Cancer 10/2016 Go to the issue

Original Article

Patient and health care provider perceptions of cancer-related fatigue and pain

Original Article

Supportive care services in hemato-oncology centers: a national survey

Erratum

Erratum: Erratum to: Effectiveness of tapentadol prolonged release for the management of painful mucositis in head and neck cancers during intensity modulated radiation therapy

Original Article

Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer

Original Article

Relationship between severity and duration of chemotherapy-induced neutropenia and risk of infection among patients with nonmyeloid malignancies

Letter to the editor

Comment on “Linfotaping with Kinesio® Tape to manage and treat lymphedema patients: safety and tolerability are more important than efficacy”
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits